Nearly one in five (19%) lost 5-10% of their baseline body weight, and 11% lost 10% or more, but that left more than two-thirds below the 5% weight-loss threshold
Our work with InScript shows whats possible when insights are paired with the right infrastructure and a partner thats committed to building together. For InScript, this approach builds on the health systems clinical and operational strengths, allowing BILH to apply its expertise to benefit design and management
This decision comes as the GLP-1 drug category continues to grow, with new treatments offering improved weight-loss results and, in some cases, reduced costs
Important Safety Information Zepbound is FDA-approved for effective weight management and metabolic health
This matters because not all melanin is the same
Many patients benefit from morning injections on their chosen day because it allows them to monitor appetite changes throughout their waking hours